李映霞, 谭文艳, 李成华, 李剑雄. 接种新型冠状病毒肺炎疫苗后出现1例过敏性休克的调查处置[J]. 上海预防医学, 2022, 34(12): 1188-1191. DOI: 10.19428/j.cnki.sjpm.2022.22075
引用本文: 李映霞, 谭文艳, 李成华, 李剑雄. 接种新型冠状病毒肺炎疫苗后出现1例过敏性休克的调查处置[J]. 上海预防医学, 2022, 34(12): 1188-1191. DOI: 10.19428/j.cnki.sjpm.2022.22075
LI Yingxia, TAN Wenyan, LI Chenghua, LI Jianxiong. Investigation and management of an anaphylactic shock case after inoculation with COVID-19 vaccine[J]. Shanghai Journal of Preventive Medicine, 2022, 34(12): 1188-1191. DOI: 10.19428/j.cnki.sjpm.2022.22075
Citation: LI Yingxia, TAN Wenyan, LI Chenghua, LI Jianxiong. Investigation and management of an anaphylactic shock case after inoculation with COVID-19 vaccine[J]. Shanghai Journal of Preventive Medicine, 2022, 34(12): 1188-1191. DOI: 10.19428/j.cnki.sjpm.2022.22075

接种新型冠状病毒肺炎疫苗后出现1例过敏性休克的调查处置

Investigation and management of an anaphylactic shock case after inoculation with COVID-19 vaccine

  • 摘要: 过敏性休克属于严重、罕见的不良反应,如不及时处理,常可危及生命。新型冠状病毒肺炎(简称“新冠病毒”)疫苗为新上市疫苗,人们对其不良反应的关注度高。本文分析1例接种新冠病毒疫苗后发生过敏性休克案例的调查处置过程,为规范接种疫苗后过敏性休克的诊断处理提供参考。

     

    Abstract: Anaphylactic shock is a serious and rare adverse reaction, which can be life-threatening if not treated in time. COVID-19 vaccine is a newly marketed vaccine, and people pay high attention to its adverse reactions. This report summarized the investigation and management process of a case of anaphylactic shock after inoculation with COVID-19 vaccine, in order to provide reference for standardizing the diagnosis and management of anaphylactic shock after vaccination.

     

/

返回文章
返回